Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid Receptor
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Low-stringency hybridization with human glucocorticoid receptor (hGR) complementary DNA was used to isolate a new gene encoding a predicted 107-kilodalton polypeptide. Expression studies demonstrate its ability to bind aldosterone with high affinity and to activate gene transcription in response to aldosterone, thus establishing its identity as the human mineralocorticoid receptor (hMR). This molecule also shows high affinity for glucocorticoids and stimulates a glucocorticoid-responsive promoter. Together the hMR and hGR provide unexpected functional diversity in which hormone-binding properties, target gene interactions, and patterns of tissue-specific expression may be used in a combinatorial fashion to achieve complex physiologic control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although certain steroids are typically categorized as glucocorticoids or mineralocorticoids, cloning and expression of the “mineralocorticoid” (glucocorticoid type 2) receptor showed it had equal affinity for both aldosterone and cortisol (568).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [568]
In the citing paper
“When stress doses of HC are administered, MCs are not needed because HC can activate MC receptors (212).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [212]
In the citing paper
“MRs have a similar affinity for aldosterone and cortisol (), but GCs circulate at to -fold higher plasma concentrations than does aldosterone.”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [162]
In the citing paper
“HSD11B2 converts cortisol to cortisone to protect the MR from activation by cortisol, thus allowing the dedicated MR agonist aldosterone to bind [[228], [229], [230], [231]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [228]
In the citing paper
“The central role of HSD11B2 is to protect mineralocorticoid target tissues from cortisol-mediated activation of the mineralocorticoid receptor (MR) (101).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [101]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90381-6 · Cited by 4,915
Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
REUL, J. M. H. M., & KLOET, E. R. D. (1985) · Endocrinology · doi:10.1210/endo-117-6-2505 · Cited by 2,580
Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes.
Miller, J., McLachlan, A. D., & Klug, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03825.x · Cited by 2,476
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
Self-citationThe c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Self-citation
Research works printed but not linked: 5
- ARMANINI, D, CHARACTERIZATION OF ALDOSTERONE BINDING-SITES IN CIRCULATING HUMAN MONONUCLEAR LEUKOCYTES, AMERICAN JOURNAL OF PHYSIOLOGY 248: E388 (1985).
- BAXTER, J.D., ENDOCRINOL METAB: 385 (1981).
- FUNDER, J.W., ADRENAL CORTEX: 86 (1985).
- Lugo, T. G., Molecular and Cellular Biology 7: 2814 (1987).
- VALLOTTON, M.B., ADRENAL CORTEX: 169 (1985).
Cited by
Items 401–500 of 1,008
Interdomain interactions in the mineralocorticoid receptor
Rogerson, F. M., & Fuller, P. J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00413-6 · Cited by 109
Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes
Kino, T., & Chrousos, G. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690437 · Cited by 109
Molecular Basis for Hypertension in the “Type II Variant” of Apparent Mineralocorticoid Excess
Li, A., Tedde, R., Krozowski, Z., Pala, A., Li, K. X. Z., Shackleton, C. H. L., Mantero, F., Palermo, M., & Stewart, P. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301955 · Cited by 109
The Drosophila gene knirps-related is a member of the steroid-receptor gene superf amily
Oro, A. E., Ong, E. S., Margolis, J. S., Posakony, J. W., Evans, R. M., & McKeown, M. (1988) · Nature · doi:10.1038/336493a0 · Cited by 109
Self-citationEvolution of adrenal and sex steroid action in vertebrates: a ligand‐based mechanism for complexity
Baker, M. E. (2003) · BioEssays · doi:10.1002/bies.10252 · Cited by 109
Muller, O. G., Parnova, R. G., Centeno, G., Rossier, B. C., Firsov, D., & Horisberger, J.-D. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000061777.67332.77 · Cited by 107
Kolber, B. J., Wieczorek, L., & Muglia, L. J. (2008) · Stress · doi:10.1080/10253890701821081 · Cited by 106
“The secretion of glucocorticoids from the adrenal cortex can readily activate two types of corticosteroid receptors in target tissues: the Type I or mineralocorticoid receptor (MR) and Type II or glucocorticoid receptor (GR; Hollenberg et al. 1985; Arriza et al. 1987).”
BackgroundBaker, M. E., Nelson, D. R., & Studer, R. A. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.10.020 · Cited by 106
Ontogeny of Type I and Type II corticosteroid receptors in the rat hippocampus
Rosenfeld, P., Sutanto, W., Levine, S., & de Kloet, E. R. (1988) · Developmental Brain Research · doi:10.1016/0165-3806(88)90206-4 · Cited by 106
Is aldosterone bad for the heart?
Funder, J. W. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.006 · Cited by 106
Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation
Ferrari, P., & Krozowski, Z. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00978.x · Cited by 106
Neuropsychopharmacological properties of neuroactive steroids
Rupprechta, R. (1999) · Steroids · doi:10.1016/s0039-128x(98)00101-9 · Cited by 105
11β‐hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation
SECKL, J. R. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00720.x · Cited by 105
Spencer, R. L., Kalman, B. A., Cotter, C. S., & Deak, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02341-6 · Cited by 105
Verrey, F., Kraehenbühl, J. P., & Rossier, B. C. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-9-1369 · Cited by 105
Binding Characteristics of Mineralocorticoid and Glucocorticoid Receptors in Dog Brain and Pituitary
REUL, J. M. H. M., DE KLOET, E. R., VAN SLUIJS, F. J., RIJNBERK, A., & ROTHUIZEN, J. (1990) · Endocrinology · doi:10.1210/endo-127-2-907 · Cited by 104
Deuchar, G. A., McLean, D. L., Hadoke, P. W. F., Brownstein, D. G., Webb, D. J., Mullins, J. J., Chapman, K. E., Seckl, J. R., & Kotelevtsev, Y. V. (2010) · Endocrinology · doi:10.1210/en.2010-0925 · Cited by 104
Drug Insight: selective agonists and antagonists of the glucocorticoid receptor
McMaster, A., & Ray, D. W. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0745 · Cited by 104
Meijer, O. C., Kalkhoven, E., van der Laan, S., Steenbergen, P. J., Houtman, S. H., Dijkmans, T. F., Pearce, D., & de Kloet, E. R. (2005) · Endocrinology · doi:10.1210/en.2004-0411 · Cited by 104
Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway?
Wehling, M., Kasmayr, J., & Theisen, K. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e719 · Cited by 104
Sloman, K. A., Desforges, P. R., & Gilmour, K. M. (2001) · Journal of Experimental Biology · doi:10.1242/jeb.204.22.3953 · Cited by 104
Morineau, G., Boudi, A., Barka, A., Gourmelen, M., Degeilh, F., Hardy, N., Al-Halnak, A., Soliman, H., Gosling, J. P., Julien, R., et al. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1397 · Cited by 103
Reul, J. M. H. M., Tonnaer, J. A. D. M., & de Kloet, E. R. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80062-9 · Cited by 103
Colocalization of Glucocorticoid and Mineralocorticoid Receptors in Human Bone
Beavan, S., Horner, A., Bord, S., Ireland, D., & Compston, J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1496 · Cited by 103
Gómez, A. M., Rueda, A., Sainte-Marie, Y., Pereira, L., Zissimopoulos, S., Zhu, X., Schaub, R., Perrier, E., Perrier, R., Latouche, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.805804 · Cited by 103
Baker, M. E., & Katsu, Y. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0661 · Cited by 103
Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies
Myles, K., & Funder, J. W. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.4.e601 · Cited by 102
Placental 11β-hydroxysteroid dehydrogenase and the programming of hypertension
Seckl, J. R., Benediktsson, R., Lindsay, R. S., & Brown, R. W. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00193-x · Cited by 102
Diederich, S., Grossmann, C., Hanke, B., Quinkler, M., Herrmann, M., Bahr, V, & Oelkers, W. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420200 · Cited by 102
Stas, S., Whaley-Connell, A., Habibi, J., Appesh, L., Hayden, M. R., Karuparthi, P. R., Qazi, M., Morris, E. M., Cooper, S. A., Link, C. D., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1691 · Cited by 102
Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear
Trune, D. R., Kempton, J. B., & Gross, N. D. (2005) · Hearing Research · doi:10.1016/j.heares.2005.10.006 · Cited by 102
KROZOWSKI, Z. S., RUNDLE, S. E., WALLACE, C., CASTELL, M. J., SHEN, J.-H., DOWLING, J., FUNDER, J. W., & SMITH, A. I. (1989) · Endocrinology · doi:10.1210/endo-125-1-192 · Cited by 101
Structure–function relationships in the mineralocorticoid receptor
Pippal, J. B., & Fuller, P. J. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0093 · Cited by 101
Coghlan, M. J., Kym, P. R., Elmore, S. W., Wang, A. X., Luly, J. R., Wilcox, D. M., Stashko, M. A., Lin, C., Miner, J. N., Tyree, C. M., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010228c · Cited by 100
Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
Funder, J. W. (2010) · Endocrinology · doi:10.1210/en.2010-0465 · Cited by 100
Diamonds are forever: the cortisone legacy
Hillier, S. G. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0309 · Cited by 100
Molecular genetic analysis of glucocorticoid signaling during mouse development
Cole, T. J., Blendy, J. A., Monaghan, A. P., Schmid, W., Aguzzi, A., & Schütz, G. (1995) · Steroids · doi:10.1016/0039-128x(94)00009-2 · Cited by 100
Glucocorticoids and renal Na + transport: implications for hypertension and salt sensitivity
Hunter, R. W., Ivy, J. R., & Bailey, M. A. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.267609 · Cited by 100
Neurosteroids: molecular mechanisms of action and psychopharmacological significance
Rupprecht, R., Hauser, C. A. E., Trapp, T., & Holsboer, F. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00233-2 · Cited by 99
Steroid receptors and vertebrate evolution
Baker, M. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110526 · Cited by 99
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease
Hadoke, P. W. F., Iqbal, J., & Walker, B. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00047.x · Cited by 99
General overview of mineralocorticoid hormone action
Agarwal, M. K., & Mirshahi, M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00038-8 · Cited by 99
Lingas, R. I., Dean, F., & Matthews, S. G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02058-2 · Cited by 99
Kanugula, A. K., Kaur, J., Batra, J., Ankireddypalli, A. R., & Velagapudi, R. (2023) · Cureus · doi:10.7759/cureus.40725 · Cited by 99
Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system
Mihailidou, A. S., & Funder, J. W. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.004 · Cited by 98
Disturbances of Na/K Balance: Pseudohypoaldosteronism Revisited
Bonny, O., & Rossier, B. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000028641.59030.b2 · Cited by 98
Luarte, A., Cisternas, P., Caviedes, A., Bátiz, L. F., Lafourcade, C., Wyneken, Ú., & Henzi, R. (2017) · Stem Cells International · doi:10.1155/2017/1719050 · Cited by 98
Aldosterone-Specific Activation of Cardiomyocyte Mineralocorticoid Receptor In Vivo
Messaoudi, S., Gravez, B., Tarjus, A., Pelloux, V., Ouvrard‐Pascaud, A., Delcayre, C., Samuel, J., Launay, J., Sierra‐Ramos, C., de la Rosa, D. Á., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.112.198986 · Cited by 98
Insights into glucocorticoid-associated hypertension
Brem, A. S. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.20637 · Cited by 98
Aldosterone: Its Receptor, Target Genes, and Actions
Pearce, D., Bhargava, A., & Cole, T. J. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01002-1 · Cited by 98
Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism
Pujo, L., Fagart, J., Gary, F., Papadimitriou, D. T., Claës, A., Jeunemaître, X., & Zennaro, M. (2006) · Human Mutation · doi:10.1002/humu.20371 · Cited by 98
Shields, P. P., Dixon, J. E., & Glembotski, C. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37799-8 · Cited by 98
Lombès, M., Binart, N., Rafestin-Oblin, M. E., Joulin, V., & Baulieu, E. E. (1993) · Biochemical Journal · doi:10.1042/bj2920577 · Cited by 97
Bradbury, M. J., Akana, S. F., Cascio, C. S., Levin, N., Jacobson, L., & Dallman, M. F. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90176-6 · Cited by 96
Mineralocorticosteroid Receptor of the chick intestine
Rafestin-Oblin, M. E., Couette, B., Radanyi, C., Lombes, M., & Baulieu, E. E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60531-9 · Cited by 96
Aldosterone Impairs Vascular Endothelial Cell Function
Hashikabe, Y., Suzuki, K., Jojima, T., Uchida, K., & Hattori, Y. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000211738.63207.c3 · Cited by 96
Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
Quattrocelli, M., Zelikovich, A. S., Salamone, I. M., Fischer, J. A., & McNally, E. M. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200556 · Cited by 96
Overexpression and characterization of the human mineralocorticoid receptor.
Alnemri, E. S., Maksymowych, A. B., Robertson, N. M., & Litwack, G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55238-8 · Cited by 96
Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor
Pippal, J. B., Cheung, C. M. I., Yao, Y., Brennan, F. E., & Fuller, P. J. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.014 · Cited by 96
Seckl, J. R., Dickson, K. L., & Fink, G. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00659.x · Cited by 95
Christ, M., Günther, A., Heck, M., Schmidt, B. M. W., Falkenstein, E., & Wehling, M. (1999) · Circulation · doi:10.1161/01.cir.99.11.1485 · Cited by 95
Mapping of estrogen receptor-producing cells in the rat brain by in situ hybridization
Pelletier, G., Liao, N., Folléa, N., & Govindan, M. V. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90264-9 · Cited by 95
Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2
Ma, X., Lian, Q.-Q., Dong, Q., & Ge, R.-S. (2011) · Toxicology · doi:10.1016/j.tox.2011.04.007 · Cited by 94
Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
Gorini, S., Kim, S. K., Infante, M., Mammi, C., Vignera, S. L., Fabbri, A., Jaffe, I. Z., & Caprio, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00584 · Cited by 94
Schneikert, J., Hübner, S., Martin, E., & Cato, A. C. B. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.929 · Cited by 94
Fuse, H., Kitagawa, H., & Kato, S. (2000) · Molecular Endocrinology · doi:10.1210/me.14.6.889 · Cited by 94
Moore, C. C., Mellon, S. H., Murai, J., Siiteri, P. K., & Miller, W. L. (1993) · Endocrinology · doi:10.1210/endo.133.1.8319583 · Cited by 93
Eplerenone Inhibits Atherosclerosis in Nonhuman Primates
Takai, S., Jin, D., Muramatsu, M., Kirimura, K., Sakonjo, H., & Miyazaki, M. (2005) · Hypertension · doi:10.1161/01.hyp.0000184640.81730.22 · Cited by 93
Apparent mineralocorticoid excess syndrome: an overview
Palermo, M., Quinkler, M., & Stewart, P. M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500015 · Cited by 92
Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs
He, B., & Wilson, E. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2135-2150.2003 · Cited by 92
Inherited Forms of Mineralocorticoid Hypertension
White, P. C. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.927 · Cited by 92
Chang, C., Kokontis, J. M., Acakpo‐Satchivi, L., Liao, S., Takeda, H., & Chang, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80028-2 · Cited by 92
Mohammed, S. F., Ohtani, T., Korinek, J. K., Lam, C. S. P., Larsen, K., Simari, R. D., Valencik, M. L., Burnett, J. C. J., & Redfield, M. M. (2010) · Circulation · doi:10.1161/circulationaha.109.915215 · Cited by 92
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
Cannavò, A., Bencivenga, L., Liccardo, D., Elia, A., Marzano, F., Gambino, G., D’Amico, M. L., Perna, C., Ferrara, N., Rengo, G., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1204598 · Cited by 91
Christ, M., Eisen, C., Aktas, J., Theisen, K., & Wehling, M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1452 · Cited by 91
Picado-Leonard, J., & Miller, W. L. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-11-1145 · Cited by 90
Huang, B. S., White, R. A., Jeng, A. Y., & Leenen, F. H. H. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90903.2008 · Cited by 90
Specificity in mineralocorticoid versus glucocorticoid action
Fuller, P. J., Lim-Tio, S. S., & Brennan, F. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00959.x · Cited by 90
The role of the 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P., Lovati, E., & Frey, F. J. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018030-00001 · Cited by 90
Ferrari, P. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00053-8 · Cited by 90
A Critical Role for Vascular Smooth Muscle in Acute Glucocorticoid-Induced Hypertension
Goodwin, J. E., Zhang, J., & Geller, D. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007080911 · Cited by 89
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 90
Lorens, S. A., Hata, N., Handa, R. J., de Kar, L. D. V., Guschwan, M. T., Góral, J., Lee, J. M., Hamilton, M. E., Bethea, C. L., & Clancy, J. J. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90047-4 · Cited by 89
Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?
Gekle, M., & Großmann, C. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0616-0 · Cited by 89
Aldosterone biosynthesis and action in vascular cells
Takeda, R., Hatakeyama, H., Takeda, Y., Iki, K., Miyamori, I., Sheng, W. P., Yamamoto, H., & Blair, I. A. (1995) · Steroids · doi:10.1016/0039-128x(94)00026-9 · Cited by 89
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Roberge, C., Carpentier, A. C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., & Gallo-Payet, N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00516.2007 · Cited by 89
11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111210 · Cited by 91
Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials
de Quervain, D. J. ‐., Wolf, O. T., & Roozendaal, B. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5116-0 · Cited by 89
Young, M. J., & Funder, J. W. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00002 · Cited by 89
Nuclear Receptors in Bone Physiology and Diseases
Imai, Y., Youn, M.-Y., Inoue, K., Takada, I., Kouzmenko, A., & Kato, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2012 · Cited by 88
Mineralocorticoid receptors in the metabolic syndrome
Zennaro, M., Caprio, M., & Fève, B. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.05.006 · Cited by 88
The human kidney is a progesterone-metabolizing and androgen-producing organ
Quinkler, M., Bumke-Vogt, C., Meyer, B., Bähr, V., Oelkers, W., & Diederich, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021970 · Cited by 87
The glucocorticoid receptor gene is in 5q–q32
Francke, U., & Foellmer, B. E. (1989) · Genomics · doi:10.1016/0888-7543(89)90287-5 · Cited by 87
Sodium transporter abundance profiling in kidney: effect of spironolactone
Nielsen, J., Kwon, T., Masilamani, S. M. E., Beutler, K. T., Hager, H., Nielsen, S., & Knepper, M. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00015.2002 · Cited by 87
Ris‐Stalpers, C., Trifiro, M. A., Kuiper, G. G. J. M., Jenster, G. W., Romalo, G., Tetsujun, S. A. I., van Rooij, H. C. J., Kaufman, M., Rosenfield, R. L., Liao, S., et al. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1562 · Cited by 87
Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor
Chen, S.-Y., Wang, J., Liu, W., & Pearce, D. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c39 · Cited by 87
Aldosterone-Regulated Sodium Transport and Blood Pressure
Tsilosani, A., Gao, C., & Zhang, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.770375 · Cited by 87
Placental growth factor mediates aldosterone-dependent vascular injury in mice
Jaffe, I. Z., Newfell, B. G., Aronovitz, M. A., Mohammad, N. N., McGraw, A. P., Perreault, R. E., Carmeliet, P., Ehsan, A., & Mendelsohn, M. E. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40205 · Cited by 87
Eul, J., Meyer, M.-É., Tora, L., Bocquel, M. T., Quirin‐Stricker, C., Chambon, P., & Gronemeyer, H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03351.x · Cited by 86
Apparent Mineralocorticoid Excess: Genotype Is Correlated With Biochemical Phenotype
Mune, T., & White, P. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1193 · Cited by 86
Metadata
- Authors
- Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M.
- Affiliations
- Salk Institute for Biological Studies (US)
- Massachusetts Institute of Technology (US)
- Venue
- Science
- Published
- 1987-07-17
- Volume
- 237
- Issue
- 4812
- Pages
- 268-275
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2015497140
- Semantic Scholar
- 81bfdef4c0560311ad90410953944d7bca1c5a08
- Cited by
- 1,946
- References
- 53
- Citations by year
- 2026: 27 · 2025: 20 · 2024: 20 · 2023: 42 · 2022: 31 · 2021: 42 · 2020: 38 · 2019: 53 · 2018: 41 · 2017: 49 · 2016: 30 · 2015: 27 · 2014: 42 · 2013: 36 · 2012: 44
- FWCI
- 67.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, glucocorticoid receptor, aldosterone, gene cloning, cDNA, aldosterone binding, transcriptional activation, glucocorticoid responsiveness, receptor structure, tissue-specific gene expression
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 4, Cloning, Molecular, DNA, DNA-Binding Proteins, Humans, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Transcription Factors, Transcription, Genetic, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.